Population-based analysis of invasive fungal infections, France, 2001-2010.
about
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus FungiAzole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?Multicenter outbreak of infections by Saprochaete clavata, an unrecognized opportunistic fungal pathogenTrends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013.Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients.Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Routine identification and mixed species detection in 6,192 clinical yeast isolates.Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database--the quality controlled standard tool for routine identification of human and animal pathogenic fungi.Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.Rapid identification of fungi in culture-negative clinical blood and respiratory samples by DNA sequence analyses.Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.Risk Factors for Cryptococcal Meningitis: A Single United States Center Experience.Epidemiology and reporting of candidaemia in Belgium: a multi-centre study.A zebrafish larval model reveals early tissue-specific innate immune responses to Mucor circinelloides.Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysisComparison of the Bruker Biotyper and VITEK MS Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Systems Using a Formic Acid Extraction Method to Identify Common and Uncommon Yeast IsolatesEpidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation UnitProspective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.The risk and clinical outcome of candidemia depending on underlying malignancy.Non-cultural methods for the diagnosis of invasive fungal disease.Our 2015 approach to invasive pulmonary aspergillosis.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK.Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools.Serious fungal diseases in the Republic of Uzbekistan.Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.Structure of the sliding clamp from the fungal pathogen Aspergillus fumigatus (AfumPCNA) and interactions with Human p21.Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa.The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).Absence of Pneumocystis jirovecii Colonization in Human Immunodeficiency Virus-Infected Individuals With and Without Airway Obstruction and With Undetectable Viral LoadUse of calcofluor-blue brightener for the diagnosis of Pneumocystis jirovecii pneumonia in bronchial-alveolar lavage fluids: A single-center prospective study.Issues in antifungal stewardship: an opportunity that should not be lost.Candidiasis and the impact of flow cytometry on antifungal drug discovery.The Changing Epidemiology of Invasive Fungal Infections.Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging.Severe cryptococcal-associated neurological immune reconstitution inflammatory syndrome in a renal transplant recipient treated with adalimumab.
P2860
Q26740363-F6E65C86-5AF8-4F22-B47F-BD3214451F82Q28068091-FDE09A0D-E2C7-4D9E-8BDA-4CE3197C7717Q28082352-FA205A36-7864-4F2A-A3CD-D1E1D334FD63Q28254032-84723071-60B0-4354-B4B7-7DBF7F1A090AQ33629045-3C320E87-BAF5-4D32-A4F3-56F1E488426CQ33688400-637E09DE-DEE2-4FDD-9846-49C4CAE81174Q33689767-41B612C7-0C86-4722-BE80-A0F1A5FB20F5Q34503341-2ECD5F25-2D79-478B-B522-752BAD085D0CQ34916656-96DA6FF3-BDA3-478C-A8F1-24D9EDB17445Q35584934-3A88923B-2E5C-4569-A011-EE838C3887AFQ36020365-2BABFA1F-D9D1-4C43-9C16-B00504C5CCD6Q36042639-82AF40C1-D48A-430D-9E36-1B111F1DE7D1Q36055572-B8BC4A0D-BF8A-4098-94B8-C2FF710E8A02Q36097979-2675DDFB-4198-4328-9F27-7A86EEC2B143Q36196229-70402453-B999-4147-A14F-23CE2D3297C1Q36245166-6ACA6C45-C841-4BC7-B9BB-938C809A4F00Q36285521-BABD9D95-B7A9-49B1-98BB-697B7F0AD6F0Q36287169-DA26E5BF-F30F-4767-AAF8-5AEB2250921DQ36834775-4736BA9C-F28F-4E34-B0D8-BC06B5F631C3Q37089475-3534734C-3BA4-4EC5-9B98-1930D9170AF8Q37631841-4EBE5D86-8862-4FBE-9535-45DD2D0FBA35Q37742252-5E10364B-EAE2-44D0-923E-82EF7E5C16B9Q38266817-57EE0937-73EF-4E0F-A283-1BFA2F8D539EQ38391049-ABAFB093-B800-4E09-B09C-917CD6DC8C38Q38610744-CDC662BA-0C00-4AFA-9303-FBB8ABCD7978Q38744413-B49E4FBF-B628-4A6D-85A4-E8B99C4CE375Q38758268-F24C5E23-A1AD-4EF4-B88F-C9FE2B09C810Q38817878-C9497ADF-17C9-4C63-B3F6-819CFD393A56Q38907928-A4B149DB-4160-4A86-8A39-71B3CA7BC427Q38912624-09CEAB57-0B4F-4F24-9700-908581AA7200Q38976873-3EA17695-EA4E-4DE4-ADA8-C9A74CA73C77Q39030370-BB28B10B-41A8-4F1A-8A27-52452261E38BQ39189670-6D67C55B-6C29-462E-85DF-348E72CA411BQ39242862-7AE97E59-9081-47C6-87DC-FCA61CF4AEE4Q39452309-BF203729-3501-430B-A5F8-66A873000821Q39581662-E74B3436-412D-4442-B801-B2B6C11D4297Q40064579-C5AEB7AF-8BE4-458B-81AC-680A03E48F2FQ40454886-D9C1387F-AF08-4684-860B-EC2ED19CB081Q40739019-27614116-5933-4CE0-B01A-78DE66590D82Q40772316-58CB5CA2-EED5-4E78-B94F-059E35DF5C03
P2860
Population-based analysis of invasive fungal infections, France, 2001-2010.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Population-based analysis of invasive fungal infections, France, 2001-2010.
@ast
Population-based analysis of invasive fungal infections, France, 2001-2010.
@en
type
label
Population-based analysis of invasive fungal infections, France, 2001-2010.
@ast
Population-based analysis of invasive fungal infections, France, 2001-2010.
@en
prefLabel
Population-based analysis of invasive fungal infections, France, 2001-2010.
@ast
Population-based analysis of invasive fungal infections, France, 2001-2010.
@en
P2093
P2860
P356
P1476
Population-based analysis of invasive fungal infections, France, 2001-2010.
@en
P2093
Bruno Coignard
Didier Che
Dounia Bitar
Françoise Dromer
Javier Nicolau
Pierre Tattevin
Yann Le Strat
P2860
P304
P356
10.3201/EID2007.140087
P577
2014-07-01T00:00:00Z